Mechanism
Midbrain dopaminergic neurons
Assets acting on this target.
- Class
- Allogeneic hESC-derived midbrain dopaminergic neuron progenitor cell therapy
- Notes
- audit finding #886 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT04802733